Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director Notice of Proposed Reorganization, 83099-83100 [2020-28074]

Download as PDF 83099 Federal Register / Vol. 85, No. 245 / Monday, December 21, 2020 / Notices and scientific organizations, and public organizations. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install, and utilize technology and systems for the purpose of collecting, validating, and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Average number of responses per respondent a 16 Potential Living Donor Registration form ............................. Potential Living Donor Follow-up form ................................ Reasons Did not Donate form (liver or kidney) ................... b 754 Total .............................................................................. Average burden per response (in minutes) Total number of responses Total burden hours a 16 112 1 106 1,792 754 1,696 .27 .50 .23 484 377 390 786 ........................ 4,242 ........................ 1,251 a Number of respondents is based on the current number of transplant programs and is likely to increase as additional programs decide to participate. b Number of living organ donor candidates submitting follow-up forms in 2019. HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2020–28017 Filed 12–18–20; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a virtual meeting. The meeting will be open to the public and public comment will be heard during the meeting. DATES: The meeting will be held February 4–5, 2021. The confirmed meeting times and agenda will be posted on the NVAC website at https:// SUMMARY: VerDate Sep<11>2014 22:33 Dec 18, 2020 Jkt 253001 www.hhs.gov/nvpo/nvac/meetings/ index.html as soon as they become available. ADDRESSES: Instructions regarding attending this meeting will be posted online at: https://www.hhs.gov/nvpo/ nvac/meetings/ at least one week prior to the meeting. Preregistration is required for those who wish to attend the meeting or participate in public comment. Please register at https://www.hhs.gov/nvpo/nvac/ meetings/. FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal Officer, at the Office of Infectious Disease and HIV/AIDS Policy, U.S. Department of Health and Human Services, Mary E. Switzer Building, Room L618, 330 C Street SW, Washington, DC 20024. Email: nvac@ hhs.gov. Phone: 202–695–9742. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of HHS was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. During this NVAC meeting, NVAC will hear presentations on vaccine safety, communication activities for COVID–19 vaccines, and immunization equity. Please note that agenda items are PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 subject to change, as priorities dictate. Information on the final meeting agenda will be posted prior to the meeting on the NVAC website: https://www.hhs.gov/ nvpo/nvac/. Members of the public will have the opportunity to provide comment at the NVAC meeting during the public comment period designated on the agenda. Public comments made during the meeting will be limited to three minutes per person to ensure time is allotted for all those wishing to speak. Individuals are also welcome to submit written comments in advance. Written comments should not exceed three pages in length. Individuals submitting comments should email their written comments or their request to provide a comment during the meeting to nvac@ hhs.gov at least five business days prior to the meeting. Dated: October 27, 2020. Ann Aikin, Acting Designated Federal Official, Office of the Assistant Secretary for Health. [FR Doc. 2020–28046 Filed 12–18–20; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director Notice of Proposed Reorganization AGENCY: National Institutes of Health, HHS. ACTION: E:\FR\FM\21DEN1.SGM Notice. 21DEN1 83100 Federal Register / Vol. 85, No. 245 / Monday, December 21, 2020 / Notices The Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) in the Office of the Director, National Institutes of Health (NIH) is seeking public comment regarding its proposal to transfer the Office of Nutrition Research (ONR) from the National Institute of Diabetes and Digestive and Kidney Diseases to DPCPSI in the Office of the Director, NIH. The program offices in DPCPSI share a common mission of identifying emerging scientific opportunities, rising public health challenges, or scientific knowledge gaps that deserve special emphasis. The proposed reorganization would align this important office with offices having similar trans-NIH functions. DATES: Any interested person may file written comments by sending an email to DPCPSIreorgcomments@nih.gov by December 29, 2020. The statement should include the individual’s name, and when applicable, professional affiliation. ADDRESSES: The following email address has been established for comments on the reorganization: DPCPSIreorgcomments@nih.gov. FOR FURTHER INFORMATION CONTACT: Robin I. Kawazoe, Deputy Director, DPCPSI, DPCPSIreorgcomments@ nih.gov, 301–402–9852. SUPPLEMENTARY INFORMATION: Pursuant to the NIH Reform Act of 2006 (42 U.S.C. Sec.281 (d)(4)), DPCPSI will launch public website information at https://dpcpsi.nih.gov/proposed-reorgONR-transfer to further encourage public discussion of the proposal to reorganize. The public is encouraged to email DPCPSIreorgcomments@nih.gov for comments and questions. SUMMARY: Dated: December 16, 2020. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health. [FR Doc. 2020–28074 Filed 12–18–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., VerDate Sep<11>2014 22:33 Dec 18, 2020 Jkt 253001 as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel NIMH Instrumentation Program (S10) Review. Date: January 11, 2021. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Nicholas Gaiano, Ph.D., Review Branch Chief, Division of Extramural Activities, National Institute of Mental Health, NIH Neuroscience Center/Room 6150/MSC 9606, 6001 Executive Boulevard, Bethesda, MD 20892–9606, 301–443–2742, nick.gaiano@nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: December 15, 2020. Patricia B. Hansberger, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–28098 Filed 12–18–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; ApoE and Alzheimer’s Disease. Date: January 22, 2021. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Video Meeting). Contact Person: Rajasri Roy, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, National Institutes of Health, Gateway Building 2W200, 7201 Wisconsin Avenue, Bethesda, MD 20892, (301) 496–6477, rajasri.roy@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: December 15, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–28005 Filed 12–18–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; ZDE1 NB 12 NIDCR New Investigator R03 Applications. Date: February 12, 2021. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Dental and Craniofacial Research, National Institutes of Health, 6701 Democracy Boulevard, Suite 668, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nisan Bhattacharyya, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, 6701 Democracy Boulevard, Suite 668, Bethesda, MD 20892, 301–451–2405, nisan_bhattacharyya@nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; NIDCR Clinical Studies SEP. Date: February 25, 2021. Time: 9:00 a.m. to 6:00 p.m. E:\FR\FM\21DEN1.SGM 21DEN1

Agencies

[Federal Register Volume 85, Number 245 (Monday, December 21, 2020)]
[Notices]
[Pages 83099-83100]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28074]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Division of Program Coordination, Planning, and Strategic 
Initiatives, Office of the Director Notice of Proposed Reorganization

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

[[Page 83100]]

SUMMARY: The Division of Program Coordination, Planning, and Strategic 
Initiatives (DPCPSI) in the Office of the Director, National Institutes 
of Health (NIH) is seeking public comment regarding its proposal to 
transfer the Office of Nutrition Research (ONR) from the National 
Institute of Diabetes and Digestive and Kidney Diseases to DPCPSI in 
the Office of the Director, NIH. The program offices in DPCPSI share a 
common mission of identifying emerging scientific opportunities, rising 
public health challenges, or scientific knowledge gaps that deserve 
special emphasis. The proposed reorganization would align this 
important office with offices having similar trans-NIH functions.

DATES: Any interested person may file written comments by sending an 
email to [email protected] by December 29, 2020. The 
statement should include the individual's name, and when applicable, 
professional affiliation.

ADDRESSES: The following email address has been established for 
comments on the reorganization: [email protected].

FOR FURTHER INFORMATION CONTACT: Robin I. Kawazoe, Deputy Director, 
DPCPSI, [email protected], 301-402-9852.

SUPPLEMENTARY INFORMATION: Pursuant to the NIH Reform Act of 2006 (42 
U.S.C. Sec.281 (d)(4)), DPCPSI will launch public website information 
at https://dpcpsi.nih.gov/proposed-reorg-ONR-transfer to further 
encourage public discussion of the proposal to reorganize. The public 
is encouraged to email [email protected] for comments and 
questions.

    Dated: December 16, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2020-28074 Filed 12-18-20; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.